Radiation Oncology · 2018 · 43 citations · 36 references
MedicineOncologyRadiation OncologyRadiation DosimetryRadiobiologyTreatment PlanningAbsorbed DoseLiver MetastasisRadiation Dose FractionationRadiation TherapyRadiation Treatment PlanningRadiobiological ModelingLiver DosimetryLiver SegmentsRadiobiological Dose ModelingRadiotherapy Dose PlanningRecirculationTherapeutic DosimetryTreatment ParametersTumor Dosimetry
Tumor immune-evasion and associated failure of immunotherapy can potentially be overcome by radiotherapy, which however also has detrimental effects on tumor-infiltrating and circulating lymphocytes (CL). We therefore established a model to simulate the radiation-dose delivered to CL. A MATLAB-model was established to quantify the CL-dose during SBRT of liver metastases by considering the factors: hepatic blood-flow, −velocity and transition-time of individual hepatic segments, as well as probability-based recirculation. The effects of intra-hepatic tumor-location and size, fractionation and treatment planning parameters (VMAT, 3DCRT, photon-energy, dose-rate and beam-on-time) were analyzed. A threshold dose ≥0.5Gy was considered inactivating CL and CL0.5 (%) is the proportion of inactivated CL. Mean liver dose was mostly influenced by treatment-modality, whereas CL0.5 was mostly influenced by beam-on-time. 3DCRT and VMAT (10MV-FFF) resulted in lowest CL0.5 values of 16 and 19%. Metastasis location influenced CL0.5, with a mean of 19% for both apical and basal and 31% for the central location. PTV-volume significantly increased CL0.5 from 27 to 67% (10MV-FFF) and from 31 to 98% (6MV-FFF) for PTV-volumes ranging from 14cm3 to 268cm3. A simulation-model was established, quantifying the strong effects of treatment-technique, tumor-location and tumor-volume on dose to CL with potential implications for immune-optimized treatment-planning in the future.
36
L. B. Rowell · Medicine & Science in Sports & Exercise · 1993 · 1.1K citations
Quantitative Assessment of the Heterogeneity of PD-L1 Expression in Non–Small-Cell Lung Cancer
Joseph McLaughlin, Gang Han, Kurt A. Schalper et al. · JAMA Oncology · 2015 · 839 citations · Full text
Medicine, Immunology, Oncology +17